4D Pharma Share Chat (DDDD)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
4D Pharma	LSE:DDDD	London	Ordinary Share	GB00BJL5BR07	ORD 0.25P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-3.00p	-2.28%	128.50p	127.00p	130.00p	127.50p	127.00p	127.50p	82,712	16:35:01

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	0.0	-24.0	-31.4	-	84.16

4D Pharma Share Discussion Threads

Showing 101 to 124 of 125 messages

Chat Pages: 5 4 3 2 1

Date	Subject	Author	Discuss
21/5/2018 07:44	Good news out today and can see this rising especially with such a catchy drug name. Duncan Peyton, 4D's Chief Executive Officer, commented: "This groundbreaking study is set to be the world's first live biotherapeutic clinical trial in oncology and the first of a number of studies we have planned to investigate MRx0518 in multiple cancer settings. The novel design of this trial provides an unrivalled opportunity to evaluate the immuno-modulatory properties of MRx0518 and how our approach using live biotherapeutics could advance a new approach to the understanding of the treatment of cancer."	ch1ck	Read Full Thread Reply
09/5/2018 08:08	I know Woodford has made some appalling calls this year but he met with management and made a judgment and bought stock.With two drugs in phase 1 and another pre clinical things are on track as per 2017 annual report.For any large company the pipeline of new drugs is crucial 4D has some exciting trials coming up this year.A bid is always a possibility but I would like to see this grow on proven sales.	ch1ck	Read Full Thread Reply
09/5/2018 07:48	SomeuwinYes your right. The share price has flattened and hopefully forming a line of resistance. The share price has been hammered way below fair value. With new products being pushed into trials we could see a rapid spike up with any good news.Exciting times	ch1ck	Read Full Thread Reply
08/5/2018 10:49	Its taken them a long time to get here. But if the trial is a success the share price sould multiply from this low level - imo	someuwin	Read Full Thread Reply
08/5/2018 08:47	I am liking the fact 4D are push the trial and info is being released.I have taken a punt and bought 8000Shares today Let's see what happens	ch1ck	Read Full Thread Reply
23/4/2018 13:30	RNS far from exciting. However share price holding up well. Any particular reason?	macarre	Read Full Thread Reply
22/3/2018 22:20	I suspect this is down due to Neil Woodford selling - due to his generally weak performance - as there is no-one to take up slack the price tanks.	rjmahan	Read Full Thread Reply
22/3/2018 21:54	Down 50% + this year, what is the story, down or a turnaround jobbie?	ny boy	Read Full Thread Reply
16/3/2018 14:42	No-one any idea ?	rjmahan	Read Full Thread Reply
21/2/2018 13:15	What is happening with this ? No news I can see driving falls. Not much volume.	rjmahan	Read Full Thread Reply
23/8/2017 12:24	Where is that sad got talking trades these days?	lukead	Read Full Thread Reply
17/8/2017 15:14	The rise was a bit sharp imo, Steady climbs are more sustainable	firw00d	Read Full Thread Reply
17/8/2017 13:11	I believe profit taking.	macarre	Read Full Thread Reply
17/8/2017 11:48	Anyone know of any reason for the drop today ?	mtness2	Read Full Thread Reply
16/8/2017 12:49	The Kid is a pathological scatologist, the Liquid refering to verbal diorheah. Filtered. No, I'm not in this one anyway.....	napoleon 14th	Read Full Thread Reply
16/8/2017 10:24	NEWS COMING, we are well into multiple trials	firw00d	Read Full Thread Reply
16/8/2017 10:08	Wow..nearly doubled my money here.Long may it continue.	talkingtrade	Read Full Thread Reply
16/8/2017 08:56	Looking good here...Loving it...	talkingtrades	Read Full Thread Reply
16/8/2017 08:16	Looks like the £3's will be behind us today, Sell 3.94 atm....Fantastic	firw00d	Read Full Thread Reply
15/8/2017 16:28	Fantastic progress over the last month.... GLAH Firwood	firw00d	Read Full Thread Reply
15/8/2017 15:09	Love this stock...	talkingtrades	Read Full Thread Reply
15/8/2017 12:13	News coming?	someuwin	Read Full Thread Reply
04/7/2017 05:54	Valued at £147 million without a product??	hybrasil	Read Full Thread Reply
13/6/2017 23:54	Under Woodford's patient fund. But clearly a long way to go. Previous performance by competitors and a thorough analysis indicates 2021 or 2022 it is the right time/year to step in, maybe at a 25p bid price. At 260p today way too expensive! IMO	berkhath	Read Full Thread Reply

Chat Pages: 5 4 3 2 1